March is National Kidney Month, which makes this a good time to learn more about the difference between two kidney disorders — kidney cysts and polycystic kidney disease. Your kidneys are situated in ...
A prolonged course of antibiotic therapy dramatically reduces the risk of recurrence in patients with renal cyst infections in the context of autosomal dominant polycystic kidney disease (ADPKD), a ...
A compound originally developed as a cancer treatment may hold promise for treating polycystic kidney disease (ADPKD), which affects more than half a million Americans and can lead to kidney ...
Polycystic kidney disease (PKD) is a debilitating hereditary condition in which fluid-filled sacs form and proliferate in the kidneys. Over time, the painful, growing cysts rob the organs of their ...
Their results indicated that cMET activity was inhibited, which in turn lowered the cell growth signals. Not only that, but according to the paper, the treatment appears also to have triggered a ...
Autosomal dominant polycystic kidney disease (ADPKD) is the most common form of polycystic kidney disease (PKD). There’s no cure for ADPKD yet. Your doctor may prescribe medications, lifestyle changes ...
MIT researchers including Robert Croy (left) and Bogdan Fedeles have discovered that a drug they originally developed as a potential cancer treatment may also hold promise in treating autosomal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results